Companies

Arcutis Biotherapeutics, Inc. (ARQT) SEC filings

CIK 0001787306 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)376.1 M3.7 M
Net income (USD)-135.7 M-42.0 M
Diluted EPS (USD/shares)-0.13-5.66

Latest filings

FiledFormDescriptionPeriod
2026-10-20144144
2026-10-194FORM 42026-10-15
2026-10-15144144
2026-10-05SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-184FORM 42026-09-16
2026-09-174FORM 42026-09-15
2026-09-16144144
2026-09-15144144
2026-09-104FORM 42026-09-08
2026-09-08144144
2026-08-284FORM 42026-08-27
2026-08-27144144
2026-08-244FORM 42026-08-20
2026-08-214FORM 42026-08-19
2026-08-20144144
2026-08-194FORM 42026-08-17
2026-08-19144144
2026-08-17144144
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-134FORM 42026-08-11
2026-08-11144144
2026-08-07SCHEDULE 13GSCHEDULE 13G
2026-08-054FORM 42026-08-03
2026-08-054FORM 42026-08-03
2026-08-054FORM 42026-08-03

Forms on file (last 1,000): 4 393, 144 154, 8-K 72, 3 31, 10-Q 20, SC 13G/A 19, SC 13D/A 15, 4/A 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ARQT (0.002 USD), /gw/filings/filings?ticker=ARQT&form=8-K, /gw/filings/facts?ticker=ARQT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange